Trials / Unknown
UnknownNCT02969239
Norepinephrine and Phenylephrine for Maternal Cardiac Output During Spinal Anesthesia for Elective Cesarean Delivery
Norepinephrine and Phenylephrine for Cesarean Section
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Jeju National University Hospital · Academic / Other
- Sex
- Female
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare norepinephrine and phenylephrine on the effects of maintaining the cardiac output in Cesarean section under spinal anesthesia.
Detailed description
CO was measured using the NICOM® monitor. Bioreactance, a development from impedance technology, is also emerging as an accessible mode of continuous CO monitoring in the operating room and can provide valuable insight into the hemodynamic effects of our interventions. This method of monitoring provides continuous CO, stroke volume (SV) and heart rate (HR) monitoring, and intermittent BP and SVR assessments at 1-minute intervals. Either phenylephrine (100 mcg/ml) or norepinephrine (0.5 mcg/ml) in 50-ml syringe that were labeled "study drug". She was not involved in patient's care or study assessment. The hypotension was defined as systolic blood pressure \<80% of baseline or \< 90 mmHg, and managed with study drug (1 ml) intravenously. The bradycardia was defined as HR \< 60 beats/min and was recorded and managed with atropine (0.5 mg) intravenously as HR \< 45 beats/min. The presence of nausea and vomiting was measured on a 3 point scale (1 = no nausea and vomiting, 2 = nausea only, and 3 = both nausea and vomiting) and managed with ondansetron (4mg) intravenously.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Norepinephrine | bolus administered norepinephrine 5mcg intravenously, if SBP \<90mmHg or 20% decrease from baseline |
| DRUG | Phenylephrine | bolus administered phenylephrine 100mcg intravenously, if SBP \<90mmHg or 20% decrease from baseline |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2016-11-21
- Last updated
- 2017-03-10
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02969239. Inclusion in this directory is not an endorsement.